Cargando…

Serum and knee synovial fluid matrixmetalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late stage osteoarthritis

OBJECTIVE: To compare the levels of MMP-13 and TNF-α in late stage osteoarthritis, define their predominant pathways and investigate their correlation with McMaster Universities Arthritis Index scores. PATIENTS AND METHODS: A total of 42 patients (mean age 64 ± 8.8) with grade 3 and grade 4 knee ost...

Descripción completa

Detalles Bibliográficos
Autores principales: Özler, Kenan, Aktaş, Erdem, Atay, Çiğdem, Yılmaz, Barış, Arıkan, Murat, Güngör, Şafak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Association of Orthopaedics and Traumatology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197357/
https://www.ncbi.nlm.nih.gov/pubmed/27932045
http://dx.doi.org/10.1016/j.aott.2015.11.003
_version_ 1783364749128368128
author Özler, Kenan
Aktaş, Erdem
Atay, Çiğdem
Yılmaz, Barış
Arıkan, Murat
Güngör, Şafak
author_facet Özler, Kenan
Aktaş, Erdem
Atay, Çiğdem
Yılmaz, Barış
Arıkan, Murat
Güngör, Şafak
author_sort Özler, Kenan
collection PubMed
description OBJECTIVE: To compare the levels of MMP-13 and TNF-α in late stage osteoarthritis, define their predominant pathways and investigate their correlation with McMaster Universities Arthritis Index scores. PATIENTS AND METHODS: A total of 42 patients (mean age 64 ± 8.8) with grade 3 and grade 4 knee osteoarthritis according to Kellegren- Lawrence criteria and who were scheduled for total knee arthroplasty were enrolled in the study. TNF-alpha and MMP-13 levels were measured preoperatively from venous blood samples and intraoperatively from knee synovial fluid via ELISA. Preoperative and 1 month postoperative knee functions were assessed by McMaster Universities Arthritis Index. RESULTS: Grade 4 synovial fluid MMP-13 (4.76 ± 5.82) was elevated compared to grade 3 (3.95 ± 4.45) (p = 0.438), whereas grade 3 serum MMP-13 (1.128 ± 0.308) was found elevated compared to grade 4 (1.038 ± 0.204) (p = 0.430). Grade 4 serum TNF-α (0.253 ± 0.277) was elevated compared to grade 3 (0.206 ± 0.219) whereas grade 3 synovial fluid TNF-α (0.129 ± 0.052) was elevated compared to grade 4 (0.118 ± 0.014). Positive correlation was observed between synovial fluid MMP-13 levels and postoperative WOMAC scores. Mean serum TNF-α level (0.226 ± 0.246 pg/ml) was found higher compared to synovial level (0.124 ± 1.59), synovial MMP-13 level (4.31 ± 1.24) was found higher compared to serum level (1.089 ± 1.519). CONCLUSION: Despite the systemic increase in TNF-α levels concordant with osteoarthritis grade, MMP-13 levels are elevated via local manner with a significant correlation with WOMAC scores. LEVEL OF EVIDENCE: Level IV, Diagnostic study.
format Online
Article
Text
id pubmed-6197357
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Turkish Association of Orthopaedics and Traumatology
record_format MEDLINE/PubMed
spelling pubmed-61973572018-10-24 Serum and knee synovial fluid matrixmetalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late stage osteoarthritis Özler, Kenan Aktaş, Erdem Atay, Çiğdem Yılmaz, Barış Arıkan, Murat Güngör, Şafak Acta Orthop Traumatol Turc Original Article OBJECTIVE: To compare the levels of MMP-13 and TNF-α in late stage osteoarthritis, define their predominant pathways and investigate their correlation with McMaster Universities Arthritis Index scores. PATIENTS AND METHODS: A total of 42 patients (mean age 64 ± 8.8) with grade 3 and grade 4 knee osteoarthritis according to Kellegren- Lawrence criteria and who were scheduled for total knee arthroplasty were enrolled in the study. TNF-alpha and MMP-13 levels were measured preoperatively from venous blood samples and intraoperatively from knee synovial fluid via ELISA. Preoperative and 1 month postoperative knee functions were assessed by McMaster Universities Arthritis Index. RESULTS: Grade 4 synovial fluid MMP-13 (4.76 ± 5.82) was elevated compared to grade 3 (3.95 ± 4.45) (p = 0.438), whereas grade 3 serum MMP-13 (1.128 ± 0.308) was found elevated compared to grade 4 (1.038 ± 0.204) (p = 0.430). Grade 4 serum TNF-α (0.253 ± 0.277) was elevated compared to grade 3 (0.206 ± 0.219) whereas grade 3 synovial fluid TNF-α (0.129 ± 0.052) was elevated compared to grade 4 (0.118 ± 0.014). Positive correlation was observed between synovial fluid MMP-13 levels and postoperative WOMAC scores. Mean serum TNF-α level (0.226 ± 0.246 pg/ml) was found higher compared to synovial level (0.124 ± 1.59), synovial MMP-13 level (4.31 ± 1.24) was found higher compared to serum level (1.089 ± 1.519). CONCLUSION: Despite the systemic increase in TNF-α levels concordant with osteoarthritis grade, MMP-13 levels are elevated via local manner with a significant correlation with WOMAC scores. LEVEL OF EVIDENCE: Level IV, Diagnostic study. Turkish Association of Orthopaedics and Traumatology 2016-12 2016-12-05 /pmc/articles/PMC6197357/ /pubmed/27932045 http://dx.doi.org/10.1016/j.aott.2015.11.003 Text en © 2016 Turkish Association of Orthopaedics and Traumatology. Publishing services by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Özler, Kenan
Aktaş, Erdem
Atay, Çiğdem
Yılmaz, Barış
Arıkan, Murat
Güngör, Şafak
Serum and knee synovial fluid matrixmetalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late stage osteoarthritis
title Serum and knee synovial fluid matrixmetalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late stage osteoarthritis
title_full Serum and knee synovial fluid matrixmetalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late stage osteoarthritis
title_fullStr Serum and knee synovial fluid matrixmetalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late stage osteoarthritis
title_full_unstemmed Serum and knee synovial fluid matrixmetalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late stage osteoarthritis
title_short Serum and knee synovial fluid matrixmetalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late stage osteoarthritis
title_sort serum and knee synovial fluid matrixmetalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late stage osteoarthritis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197357/
https://www.ncbi.nlm.nih.gov/pubmed/27932045
http://dx.doi.org/10.1016/j.aott.2015.11.003
work_keys_str_mv AT ozlerkenan serumandkneesynovialfluidmatrixmetalloproteinase13andtumornecrosisfactoralphalevelsinpatientswithlatestageosteoarthritis
AT aktaserdem serumandkneesynovialfluidmatrixmetalloproteinase13andtumornecrosisfactoralphalevelsinpatientswithlatestageosteoarthritis
AT ataycigdem serumandkneesynovialfluidmatrixmetalloproteinase13andtumornecrosisfactoralphalevelsinpatientswithlatestageosteoarthritis
AT yılmazbarıs serumandkneesynovialfluidmatrixmetalloproteinase13andtumornecrosisfactoralphalevelsinpatientswithlatestageosteoarthritis
AT arıkanmurat serumandkneesynovialfluidmatrixmetalloproteinase13andtumornecrosisfactoralphalevelsinpatientswithlatestageosteoarthritis
AT gungorsafak serumandkneesynovialfluidmatrixmetalloproteinase13andtumornecrosisfactoralphalevelsinpatientswithlatestageosteoarthritis